RET基因变异肿瘤的靶向治疗现状(5)
[21] Camidge D R，Dziadziuszko R，Peters S，et al.Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase Ⅲ ALEX Study[J].Journal of Thoracic Oncology ......
您现在查看是摘要页，全文长 1867 字符。